Ligand validation:8VZA

UQ3: S-{(3S,5R,9R)-1-[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]-3,5,9-trihydroxy-8,8-dimethyl-3,5,10,14-tetraoxo-2,4,6-trioxa-11,15-diaza-3lambda~5~,5lambda~5~-diphosphaheptadecan-17-yl} (2R)-2-hydroxypropanethioate

UQ3 is a Ligand Of Interest in 8VZA designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8VZA_UQ3_D_602	100%	47%	0.029	0.994	0.92	1.13	2	3	0	0	94%	0.97
8VZA_UQ3_A_602	100%	48%	0.03	0.994	0.82	1.19	1	3	1	0	94%	0.94
8VZA_UQ3_B_603	100%	46%	0.03	0.994	0.88	1.21	1	3	0	0	94%	0.98
8VZA_UQ3_C_602	100%	47%	0.034	0.994	0.92	1.13	3	1	0	0	94%	0.96
8VZB_UQ3_A_603	91%	26%	0.071	0.957	1.69	1.29	4	6	0	0	100%	0.97
8E6O_UQ3_A_701	56%	62%	0.122	0.892	0.68	0.77	1	2	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.